The co-chairs of the writing committee for the “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease” answer our questions about the updated guideline and why aspirin is no longer...
He discusses his research on scaling up pharmacist-led blood pressure control programs in black barbershops, how these programs would affect long-term population health and cost of health care, and more.
...
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
In his session at this year's Cardiometabolic Risk Summit, Dr Grumet discusses how sharing your story with patients via social media and other avenues can help bridge the intimacy gap.
In this podcast, W. Clay Jackson, MD, DipTh, defines burnout and related phenomena, discusses contributing demographic and related factors, and names ways to help alleviate burnout.
In this podcast, W. Clay Jackson, MD, DipTh, defines burnout and related phenomena, discusses contributing demographic and related factors, and names ways to help alleviate burnout.
In this podcast, Robert P. Giugliano, MD, discusses the safety and efficacy findings from IMPROVE-IT, the practical implications for ezetimibe, and more.
She talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our...
